Filtered By:
Vaccination: Veterinary Vaccinations
This page shows you your search results in order of relevance. This is page number 16.
Order by Relevance | Date
Total 406 results found since Jan 2013.
Vaccines as therapies for food allergies
Adv Pharmacol. 2021;91:229-258. doi: 10.1016/bs.apha.2021.01.003. Epub 2021 Mar 4.ABSTRACTFood allergy is a growing public health epidemic with few available treatments beyond allergen avoidance and rescue medications for accidental exposures. A major focus of therapeutic development for food allergies is allergen-specific immunotherapy (AIT) in which patients are exposed to increasing amounts of allergen in controlled dosing to induce desensitization or tolerance. The work of the past few decades has culminated in the recent FDA approval of a peanut product for oral AIT for peanut allergies. Despite these advances, curren...
Source: Advances in Pharmacology - June 8, 2021 Category: Drugs & Pharmacology Authors: Jeffrey J Landers Jessica J O'Konek Source Type: research
BCG for the prevention and treatment of allergic asthma
Vaccine. 2021 Aug 17:S0264-410X(21)00997-X. doi: 10.1016/j.vaccine.2021.07.092. Online ahead of print.ABSTRACTAllergic diseases, in particular atopic asthma, have been on the rise in most industrialized countries for several decades now. Allergic asthma is characterized by airway narrowing, bronchial hyperresponsiveness, excessive airway mucus production, eosinophil influx in the lungs and an imbalance of the Th1/Th2 responses, including elevated IgE levels. Most available interventions provide only short-term relief from disease symptoms and do not alter the underlying immune imbalance. A number of studies, mostly in mous...
Source: Vaccine - August 21, 2021 Category: Allergy & Immunology Authors: Magdalena Kowalewicz-Kulbat Camille Locht Source Type: research
Vaccines as therapies for food allergies
Adv Pharmacol. 2021;91:229-258. doi: 10.1016/bs.apha.2021.01.003. Epub 2021 Mar 4.ABSTRACTFood allergy is a growing public health epidemic with few available treatments beyond allergen avoidance and rescue medications for accidental exposures. A major focus of therapeutic development for food allergies is allergen-specific immunotherapy (AIT) in which patients are exposed to increasing amounts of allergen in controlled dosing to induce desensitization or tolerance. The work of the past few decades has culminated in the recent FDA approval of a peanut product for oral AIT for peanut allergies. Despite these advances, curren...
Source: Advances in Pharmacology - June 8, 2021 Category: Drugs & Pharmacology Authors: Jeffrey J Landers Jessica J O'Konek Source Type: research
BCG for the prevention and treatment of allergic asthma
Vaccine. 2021 Aug 17:S0264-410X(21)00997-X. doi: 10.1016/j.vaccine.2021.07.092. Online ahead of print.ABSTRACTAllergic diseases, in particular atopic asthma, have been on the rise in most industrialized countries for several decades now. Allergic asthma is characterized by airway narrowing, bronchial hyperresponsiveness, excessive airway mucus production, eosinophil influx in the lungs and an imbalance of the Th1/Th2 responses, including elevated IgE levels. Most available interventions provide only short-term relief from disease symptoms and do not alter the underlying immune imbalance. A number of studies, mostly in mous...
Source: Vaccine - August 21, 2021 Category: Allergy & Immunology Authors: Magdalena Kowalewicz-Kulbat Camille Locht Source Type: research
Vaccines as therapies for food allergies
Adv Pharmacol. 2021;91:229-258. doi: 10.1016/bs.apha.2021.01.003. Epub 2021 Mar 4.ABSTRACTFood allergy is a growing public health epidemic with few available treatments beyond allergen avoidance and rescue medications for accidental exposures. A major focus of therapeutic development for food allergies is allergen-specific immunotherapy (AIT) in which patients are exposed to increasing amounts of allergen in controlled dosing to induce desensitization or tolerance. The work of the past few decades has culminated in the recent FDA approval of a peanut product for oral AIT for peanut allergies. Despite these advances, curren...
Source: Advances in Pharmacology - June 8, 2021 Category: Drugs & Pharmacology Authors: Jeffrey J Landers Jessica J O'Konek Source Type: research
Nanoparticle with mRNA appears to prevent, treat peanut allergies in mice
Key takeawaysPeanuts are one of the most common food allergens for children.UCLA scientists have developed a nanoparticle that delivers mRNA to liver cells in order to teach the immune system to tolerate peanut protein and alleviate allergies.In mice, the nanoparticle successfully dampened symptoms of serious allergy.Peanut allergies affect 1 in 50 children, and the most severe cases lead to a potentially deadly immune reaction called anaphylactic shock.Currently, there is only one approved treatment that reduces the severity of the allergic reaction, and it takes months to kick in. A group of UCLA immunologists is aiming ...
Source: UCLA Newsroom: Health Sciences - April 3, 2023 Category: Universities & Medical Training Source Type: news
Why It Took So Long to Finally Get an RSV Vaccine
Respiratory syncytial virus (RSV) can dangerously compromise breathing, especially for infants and the elderly. But there has been no vaccine to prevent it—until today. On May 3, the U.S. Food and Drug Administration (FDA) approved the first vaccine against RSV, from GlaxoSmithKline (GSK), to prevent respiratory disease in people ages 60 and older. The Centers for Disease Control’s vaccine committee will make formal recommendations in June about who should receive the vaccine, but GSK says it currently has enough doses to vaccinate eligible people beginning this fall.
In studies involving 25,000 people that GSK...
Source: TIME: Health - May 3, 2023 Category: Consumer Health News Authors: Alice Park Tags: Uncategorized Drugs healthscienceclimate Source Type: news
Comparison of antiallergic effects of pneumococcal conjugate vaccine and pneumococcal polysaccharide vaccine in a murine model of allergic rhinitis
Conclusion and Clinical RelevanceBoth PV and PCV suppressed the allergen‐specific T helper 2 response and induced regulatory T cells in a murine model of allergic rhinitis. However, PV and PCV may activate Treg cells via different mechanisms.
Level of EvidenceN/A. Laryngoscope, 2013
Source: The Laryngoscope - February 16, 2013 Category: ENT & OMF Authors: Boo‐Young Kim, Ji‐Hyeon Shin, Hyang Rim Park, Sung Won Kim, Soo Whan Kim Tags: Allergy/Rhinology Source Type: research
Novel approach for influenza vaccination shows promise in early animal testing
(NIH/National Institute of Allergy and Infectious Diseases) A new approach for immunizing against influenza elicited a more potent immune response and broader protection than the currently licensed seasonal influenza vaccines when tested in mice and ferrets. The vaccine concept, which was developed by scientists at NIAID, represents an important step forward in the quest to develop a universal influenza vaccine -- one that would protect against most or all influenza strains without the need for an annual vaccination.
Source: EurekAlert! - Medicine and Health - May 22, 2013 Category: Global & Universal Source Type: news
Veterinary Hospital in Tampa Celebrates 10th Anniversary With Free Pet Diagnostic Services
TAMPA, Fla., June 16, 2013 (GLOBE NEWSWIRE) -- Cross Creek Animal Medical Centre in Tampa, FL announced that the veterinary hospital is celebrating its 10th anniversary this summer. In celebration of the animal hospital's 10th anniversary, the vet clinic is offering the following services for free: heartworm testing, microchip insert or an intestinal parasite test. In addition to the free anniversary services, the veterinary hospital is equipped to provide pet acupuncture, custom and holistic therapies, wellness packages, pet vaccinations, allergy testing, DNA testing, lab work, digital radiology, ultrasounds, pet dental c...
Source: Medical News (via PRIMEZONE) - June 16, 2013 Category: Pharmaceuticals Source Type: news
New malaria vaccine could save millions of lives
Conclusion
This is a promising step in the long struggle by scientists to develop a safe and effective vaccine against P. falciparum malaria. However, this was a tiny, early stage study and more research is required to replicate the results and to look further at the potential effectiveness of different doses. It is not certain how long such a vaccine may offer protection for and also, whether it would protect against other strains than the one tested here.
Travellers to malarial areas are strongly advised to avoid mosquito bites by using insect repellent and mosquito nets, and by covering up at all times. Medication ma...
Source: NHS News Feed - August 9, 2013 Category: Consumer Health News Tags: Medication Medical practice Source Type: news
